Clinical trial
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
NCT00373347 · Stanford University, Other · Recruiting
Key facts
| NCT number | NCT00373347 |
|---|---|
| Title | Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma |
| Official title | Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma |
| Lead sponsor | Stanford University, Other |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Liver Cancer |
| Enrollment | 600 |
| Start date | Nov 1, 2004 |
| Primary completion | Dec 1, 2025 |
| Completion | Dec 1, 2025 |
| First posted | Sep 8, 2006 |
| Last update posted | May 4, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: